The programme is pan-African and rolling, which aligns with the venture's Nigeria-first, Africa-focused digital health access angle. However, the snippet emphasizes 'creativetech' startups, so the fit is moderate; the applicant's regulatory-heavy e-pharmacy model may not be the primary target. Still, the rolling deadline and incubation format make it worth applying.